Team:KU Leuven/Safety

From 2013.igem.org

(Difference between revisions)
Line 145: Line 145:
</div>
</div>
 +
<div class="row-fluid">
 +
<div class="span12 white">
 +
  <h3>Auxotrophic mechanism</h3>
 +
  <div class="row-fluid">
-
</html>
+
  <div class="span6">
-
Our safety form was received and approved by the iGEM Safety Committee on September 29, 2013.
+
    <p align="justify"
 +
Researchers have already been using organisms in labs for decades and so far, no bio-hazardous incidents have been traced back to them. This gives the impression that genetically modified bacteria are not dangerous. However, since the genes of engineered bacteria are enhanced or modified, they might mutate in a super-bacterium which cannot be controlled anymore.(Moe-Behrens, Davis, & Haynes, 2013)<br/>
 +
Therefore, we need a genetic safeguard, which prevents that microbes escape from proliferating unchecked and to prevent the spread of engineered genetic material into unintended host cells. This is necessary, especially if the speculations correctly predict the future use of synthetic biology. The use of genetically modified bacteria will scale to large industrial volumes, introduce large numbers of synthetic organisms into the environment for bioremediation, and be used in private spaces where dispersal and disposal are difficult to monitor.<br/>
 +
We, the KU Leuven iGEM team of 2013, propose the use of an auxotrophic mechanism as a genetic safeguard. <br/>
 +
The basic mechanism is based on the fact that, since auxotrophic organisms are unable to synthesize an essential compound required for their survival, they rapidly die once they escape the controlled environment where the compound is supplied.<br/>
 +
Already in 1987, Molin and colleagues designed a DNA cassette that functions as a conditional suicide system in any healthy bacterial strain. In the absence of an artificially supplied growth supplement, the cassette produced a toxic protein that damages bacterial cell membranes and kills the cells. Also, stochastic activation of this toxic component could be used to kill a predetermined fraction of cells per unit of time. This helps to tune the level of lethality so that an optimal level of bioproduction is achieved.(Moe-Behrens et al., 2013)<br/>
 +
This year, we present two models in which the use of an auxotrophic mechanism can be easily manifested, especially for the "sticker" or "oscillator" model.<br/>
 +
However, auxotrophic mechanisms might be difficult to manage in our "spray" or "glucose" model. </p>
 +
  </div>
 +
  <div class="span6 greytext">
 +
    <img src="https://static.igem.org/mediawiki/2013/4/4c/Genetic_safeguard_strategies.jpg" alt="genetic safeguard strategies"><p align="justify"><b>Genetic safeguard strategies.</b><br/>
 +
Recombinant DNA (bright green) is introduced into the host chromosome (white wavy lines). Two pathways for engineered auxotrophy (A,B) kill synthetic organisms (blue) once they lose access to a supplement (+) in a controlled environment. The supplement either (A) suppresses a toxic gene product (−) or (B) provides nutrition to compensate for a genetic deletion (red X). The induced lethality system (C) produces a toxic gene product (−) in response to an inducer (i) such as IPTG, sucrose, arabinose, or heat. (Moe-Behrens <i>et al.</i>, 2013)</p>
 +
  </div>
-
== Risk assessments for the experiments we performed in the lab ==
+
  </div>
-
* [https://static.igem.org/mediawiki/2013/8/89/Risk_assessment_agarose_gel_electrophoresis_KULeuven.pdf Risk assessment for agarose gel electrophoresis]
+
</div>
 +
</div>
-
*[https://static.igem.org/mediawiki/2013/d/d8/Risk_assessment_PCR_Purification_Kit_KULeuven.pdf Risk assessment for PCR purification kit]
 
-
*[https://static.igem.org/mediawiki/2013/7/7b/Risk_assessment_PCR_KULeuven.pdf Risk assessment for PCR]
+
</html>
-
 
+
Our safety form was received and approved by the iGEM Safety Committee on September 29, 2013.
-
*[https://static.igem.org/mediawiki/2013/8/8f/Risk_assessment_Plasmid_DNA_Purification_kit_KULeuven.pdf Risk assessment for plasmid DNA purification kit]
+
-
 
+
-
*[https://static.igem.org/mediawiki/2013/f/f6/Risk_assessment_transformation_of_bacteria_KULeuven.pdf Risk assessment for transformation of bacteria]
+
-
 
+
-
*[https://static.igem.org/mediawiki/2013/1/1b/Risk_assessment_use_of_pH_electrode_and_preparation_of_buffers_KULeuven.pdf Risk assessment for pH electrode and preparation of buffers]
+

Revision as of 15:18, 3 October 2013

iGem

Secret garden

Congratulations! You've found our secret garden! Follow the instructions below and win a great prize at the World jamboree!


  • A video shows that two of our team members are having great fun at our favourite company. Do you know the name of the second member that appears in the video?
  • For one of our models we had to do very extensive computations. To prevent our own computers from overheating and to keep the temperature in our iGEM room at a normal level, we used a supercomputer. Which centre maintains this supercomputer? (Dutch abbreviation)
  • We organised a symposium with a debate, some seminars and 2 iGEM project presentations. An iGEM team came all the way from the Netherlands to present their project. What is the name of their city?

Now put all of these in this URL:https://2013.igem.org/Team:KU_Leuven/(firstname)(abbreviation)(city), (loose the brackets and put everything in lowercase) and follow the very last instruction to get your special jamboree prize!

tree ladybugcartoon

We have covered the safety aspect of our project in many ways. Within synthetic biology there are three main risks that have to be covered: exposition of the laboratory workers to the bacteria and chemicals, effects of a possible escape of the bacteria and the unintentional disturbance of the ecosystem.
We received extra safety training at the beginning of the project. On top of that we took courses regarding safety aspects, e.g. ‘Safe Microbiological Practices’. The safety training consisted of a summaryof the important biosafety issues and the composition of the lab.

Laurens Labo
some_text

(Max Gibson)

In the past three months, we tried to add new branches to the pathways of E. coli. Our experiments were performed with non-pathogenic E. coli strains (BL21, DH5α, TOP10 and Rosetta(DE3)pLysS), which belong to risk group 1of the pathogenic organisms. Working with genetically modified organisms needs extra safety conditions, physical measures are taken to separatethe organism form the surrounding environment and vice versa.
Our project wants to protect plants and crops against aphid infestations and reduce the use of harmful insecticides. Our genetically modified bacteria will produce (E)-β-farnesene (EBF) and methyl salicylate (MeS), which are natural occurring substances. EBF repels aphids and MeS attracts ladybugs, one of their natural enemies. The low concentrations needed to be effective are not toxic for humans. No harmful effects are described for EBF at high concentrations either. Contrarily, pure MeS could cause harm when it is ingested due to its similarities with acetylsalicylic acid (aspirin) and can cause irritation after contact with eyes and skin. Although, it is typically used in small amounts as a flavouring agent, in candy or as fragrance oils due to its mint flavour and wintergreen fragrance. The two chemicals being produced by our BioBricks could cause allergic reactions (swelling, redness, ...), but serious reactions are very rare.
The effect of our genetically modified bacteria on the environment is non-trivial and thorough field experiments must definitely be conducted. The maximum production rate of onebacterium has to be determined and scaling this model up to a whole field occupied by our bacteria will allow us to estimate the concentration in the surroundings. We can then determine the necessary parameters in order to minimise ecological disruption according to surrounding concentrations of MeS and EBF. We also thought about the interactions between aphids and ladybugs themselves. Aphids adapt readily when EBF is constantly present,therefore we included an oscillatory model. More information about this model can be found here .

Legislation in Belgium & Europe

In Belgium, the whole research about genetically modified organisms (GMOs) is subjected to strict safety legislation. These laws must protect the people and the environment against the potential risks of the GMOs. The European legislation forms the foundation of the more extensive Belgian laws. Firstly, the use of GMOs in Europe requires an environmental licence. In Belgium, an approval for the research activity is required on top of that. This way the Belgian government controls all use of GMO’s and can assess risk analysis accurately. This is all recorded in the Decrees of the Flemish Government: Vlarem I and II section 51. The Belgian government describes four risk levels to which different restrictions are coupled. These restrictions are a combination of physical actions and safety regulations. For this purpose, the Belgian government appeals to the expertise of the Advisory Board of Biosafety (ABB). The ABB (section Biosafety and biotechnology of the Scientific Institute of Public Health) forms the scientific secretariat of the board. They evaluate the risk analysis in the licence request. At the KU Leuven, all the laboratories, including the iGEM lab, have an environmental licence and an approval for their activities.

some_text

(JRC - European Commission)

University of Leuven Rules

The University of Leuven has its own biosafety rules in addition to the national biosafety regulations, where Marianne Schoukens acts as the central contact point for Health, Safety and Environment (HSE) issues. All members of our team have received training in Safe Microbiological Techniques as well as general and specific lab safety required by the University of Leuven. At the beginning of our project, all members of the iGEM team have received an update from the KU HSE department. Via liaison Iris Govaerts, we followed a small seminar and filled in an orientation checklist concerning health and safety training prior to the start of project laboratory work.
The project we ultimately chose was the result of a whole series of brainstorm sessions. In this brainstorm sessions we talked about the feasibility of our ideas with our instructor (Dr. Ir. Ingmar Claes) and our coordinators (Prof.Dr. Johan Robben and Dr.Veerle De Wever). We also invited different PhD students, professors, ex-iGEMers and people from the industrial sector to our brainstorm sessions. These people have a lot more knowledge about the specific topics and could help us greatly with our decisions. Once the project was in progress, we also contacted a lot of people with questions and about possibilities. All these people had another view on our project and helped us taking into account different issues about the safety of our project: the molecules that our bacteria will produce, release into the environment, etc ...

If our project would be used around the country or in the whole world, many parameters would need to be determined. As stated earlier, the pheromones produced by the modified E.coli are not harmful for our health unless available in high concentrations. So when this modified E.coli would be spread across acres of land, the concentration of pheromones could attain a high level. The ceiling of this production would need to be determined to see whether it could be a harmful concentration for our health. Insects however do not need as high of a concentration as humans do to develop a reaction. Therefore the disruption of the ecosystem would need to be considered as well. As with most products released in the environment, its bioaccumulation needs to be at a minimum.

(Norcal)

some_text
some_text

In all our experiments, we used non-pathogenic E. coli strains. These strains are not harmful for humans, except when they are inhaled or swallowed. Nevertheless, they can cause irritation to the eyes and/or skin. The chemicals that are produced by our genetically modified E. coli strain are natural molecules and are not harmful for the environment. An accidental release of our bacteria into the environment could have unexpected effects on the ecological balance.As suggested in literature (reference), containment through engineered auxotrophy so that our genetically modified E. coli is unable to synthesise an essential compound required for their survival, is the most reliable method currently for biocontainment. We propose the use of a tryptophan auxotrophic bacterium.
When tryptophan auxotrophic bacteria will be used in our project, we must provide tryptophan in their medium. This is possible when the bacteria grow together on a petri dish or another closed environment, but not when we want to spray the bacteria on the plants and crops. Therefore we designed two models. In one model the bacteria are grown in a contained environment, a plastic sticker (Design of Groningen iGEM 2012), where the auxotrophic mechanism can be used. This plastic sticker is composed of a plastic film with pores that are too small for the bacteria, but through which our volatiles (EBF and MeS) can escape.
In the second model we have designed, the bacterium would be free in the environment and thus not contained in an enclosed container with medium therefore an auxotrophic mechanism would not be applicable. Here we turn to a ‘kill switch’ or induced lethality mechanism, which is less reliable because of spontaneous mutations that could inactivate or disable this ‘kill switch’. Different kill switches are already being used in the iGEM competition. When we would chose for this method, we have to examine all the available kill switches and select the best one.

Auxotrophic mechanism

Therefore, we need a genetic safeguard, which prevents that microbes escape from proliferating unchecked and to prevent the spread of engineered genetic material into unintended host cells. This is necessary, especially if the speculations correctly predict the future use of synthetic biology. The use of genetically modified bacteria will scale to large industrial volumes, introduce large numbers of synthetic organisms into the environment for bioremediation, and be used in private spaces where dispersal and disposal are difficult to monitor.
We, the KU Leuven iGEM team of 2013, propose the use of an auxotrophic mechanism as a genetic safeguard.
The basic mechanism is based on the fact that, since auxotrophic organisms are unable to synthesize an essential compound required for their survival, they rapidly die once they escape the controlled environment where the compound is supplied.
Already in 1987, Molin and colleagues designed a DNA cassette that functions as a conditional suicide system in any healthy bacterial strain. In the absence of an artificially supplied growth supplement, the cassette produced a toxic protein that damages bacterial cell membranes and kills the cells. Also, stochastic activation of this toxic component could be used to kill a predetermined fraction of cells per unit of time. This helps to tune the level of lethality so that an optimal level of bioproduction is achieved.(Moe-Behrens et al., 2013)
This year, we present two models in which the use of an auxotrophic mechanism can be easily manifested, especially for the "sticker" or "oscillator" model.
However, auxotrophic mechanisms might be difficult to manage in our "spray" or "glucose" model.

genetic safeguard strategies

Genetic safeguard strategies.
Recombinant DNA (bright green) is introduced into the host chromosome (white wavy lines). Two pathways for engineered auxotrophy (A,B) kill synthetic organisms (blue) once they lose access to a supplement (+) in a controlled environment. The supplement either (A) suppresses a toxic gene product (−) or (B) provides nutrition to compensate for a genetic deletion (red X). The induced lethality system (C) produces a toxic gene product (−) in response to an inducer (i) such as IPTG, sucrose, arabinose, or heat. (Moe-Behrens et al., 2013)

Our safety form was received and approved by the iGEM Safety Committee on September 29, 2013.